Treatment of bleeding in dialysis patients

Seminars in Dialysis

Volumn 22, Issue 3, 2009, Pages 279-286

  Galbusera, Miriam ^a   Remuzzi, Giuseppe ^a,b   Boccardo, Paola ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 7A; CONJUGATED ESTROGEN; ESTROGEN; HEMOSTATIC AGENT; TRANEXAMIC ACID;

BLEEDING; BLOOD; BLOOD CLOTTING; DRUG EFFECT; HUMAN; METABOLISM; RENAL REPLACEMENT THERAPY; REVIEW; THROMBOCYTE; TREATMENT OUTCOME; UREMIA;

ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; BLOOD PLATELETS; ESTROGENS; ESTROGENS, CONJUGATED (USP); FACTOR VIIA; HEMORRHAGE; HEMOSTATICS; HUMANS; RENAL DIALYSIS; TRANEXAMIC ACID; TREATMENT OUTCOME; UREMIA;

EID: 67649628258     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00556.x     Document Type: Review

References (104)

1. Remuzzi G : Bleeding disorders in uremia: pathophysiology and treatment. Adv Nephrol Necker Hosp 18 : 171 186, 1989
2. Eiser AR : Gastrointestinal bleeding in maintenance dialysis patients. Semin Dial 1 : 198 202, 1988
3. Doherty CC : Gastrointestinal bleeding in dialysis patients. Nephron 63 : 132 136 discussion 137-139, 1993
4. Stassen JM, Arnout J, Deckmyn H : The hemostatic system. Curr Med Chem 11 : 2245 2260, 2004 (Pubitemid 39172347)
5. Ruggeri ZM : von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 1 : 1335 1342, 2003
6. Lopez JA, Dong JF : Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells. Semin Hematol 41 : 15 23, 2004 (Pubitemid 38057781)
7. Fay WP, Garg N, Sunkar M : Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol 27 : 1231 1237, 2007 (Pubitemid 46809410)
8. Joist JH, Remuzzi G, Mannucci PM : Abnormal bleeding and thrombosis in renal disease. In : Colman RW, Hirsh J, Marder VJ, Salzman HW (eds). Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia : Lippincott JB, 1994 : 921 935
9. Panicucci F, Sagripanti A, Pinori E, Vispi M, Lecchini L, Barsotti G, Giovannetti S : Comprehensive study of haemostasis in chronic uraemia. Nephron 33 : 5 8, 1983 (Pubitemid 13173053)
10. Hakim RM, Schafer AI : Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 78 : 575 580, 1985 (Pubitemid 15091280)
11. Knudsen F, Nielsen AH, Kristensen SD : The effect of dialyser membrane material on intradialytic changes in platelet count, platelet aggregation, circulating platelet aggregates and antithrombin III. Scand J Urol Nephrol 19 : 227 232, 1985 (Pubitemid 15246688)
12. Hall AV, Clark WF, Parbtani A : Heparin-induced thrombocytopenia in renal failure. Clin Nephrol 38 : 86 89, 1992
13. Tassies D, Reverter JC, Cases A, Escolar G, Villamor N, Lopez-Pedret J, Castillo R, Ordinas A : Reticulated platelets in uremic patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis. Am J Hematol 50 : 161 166, 1995
14. Di Minno G, Martinez J, McKean ML, De La Rosa J, Burke JF, Murphy S : Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med 79 : 552 559, 1985 (Pubitemid 16191207)
15. Eknoyan G, Brown CH 3rd. : Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol 1 : 17 23, 1981 (Pubitemid 12227790)
16. Kyrle PA, Stockenhuber F, Brenner B, Gossinger H, Korninger C, Pabinger I, Sunder-Plassmann G, Balcke P, Lechner K : Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure. Thromb Haemost 60 : 205 208, 1988 (Pubitemid 18271741)
17. Vlachoyannis J, Schoeppe W : Adenylate cyclase activity and cAMP content of human platelets in uraemia. Eur J Clin Invest 12 : 379 381, 1982
18. Jacobsson B, Ransnas L, Nyberg G, Bergh CH, Magnusson Y, Hjalmarson A : Abnormality of adenylate cyclase regulation in human platelet membranes in renal insufficiency. Eur J Clin Invest 15 : 75 81, 1985 (Pubitemid 15109229)
19. Gura V, Creter D, Levi J : Elevated thrombocyte calcium content in uremia and its correction by 1 alpha(OH) vitamin D treatment. Nephron 30 : 237 239, 1982
20. + in platelets from patients with uremia. Blood 73 : 172 176, 1989 (Pubitemid 19040972)
21. Smith MC, Dunn MJ : Impaired platelet thromboxane production in renal failure. Nephron 29 : 133 137, 1981 (Pubitemid 12242845)
22. Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, De Gaetano G, Day SS, Smith WL, Pinca E, Patrignani P, Patrono C : Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect. J Clin Invest 71 : 762 768, 1983 (Pubitemid 13160825)
23. Macconi D, Vigano G, Bisogno G, Galbusera M, Orisio S, Remuzzi G, Livio M : Defective platelet aggregation in response to platelet-activating factor in uremia associated with low platelet thromboxane A2 generation. Am J Kidney Dis 19 : 318 325, 1992
24. Escolar G, Diaz-Ricart M, Cases A, Castillo R, Ordinas A, White JG : Abnormal cytoskeletal assembly in platelets from uremic patients. Am J Pathol 143 : 823 831, 1993 (Pubitemid 24058238)
25. Castillo R, Lozano T, Escolar G, Revert L, Lopez J, Ordinas A : Defective platelet adhesion on vessel subendothelium in uremic patients. Blood 68 : 337 342, 1986 (Pubitemid 16050650)
26. Zwaginga JJ, Ijsseldijk MJ, Beeser-Visser N, de Groot PG, Vos J, Sixma JJ : High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood. Blood 75 : 1498 1508, 1990 (Pubitemid 20114890)
27. Escolar G, Cases A, Bastida E, Garrido M, Lopez J, Revert L, Castillo R, Ordinas A : Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa. Blood 76 : 1336 1340, 1990 (Pubitemid 20342748)
28. Benigni A, Boccardo P, Galbusera M, Monteagudo J, De Marco L, Remuzzi G, Ruggeri ZM : Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia. Am J Kidney Dis 22 : 668 676, 1993 (Pubitemid 23330935)
29. Sreedhara R, Itagaki I, Hakim RM : Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors. Am J Kidney Dis 27 : 355 364, 1996 (Pubitemid 26075844)
30. Turney JH, Woods HF, Fewell MR, Weston MJ : Factor VIII complex in uraemia and effects of haemodialysis. Br Med J (Clin Res Ed) 282 : 1653 1656, 1981 (Pubitemid 11111296)
31. Livio M, Mannucci PM, Vigano G, Mingardi G, Lombardi R, Mecca G, Remuzzi G : Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315 : 731 735, 1986 (Pubitemid 16054988)
32. Remuzzi G, Marchesi D, Livio M, Schieppati A, Mecca G, Donati MB, de Gaetano G : Prostaglandins, plasma factors and haemostasis in uremia. In : Remuzzi G, Mecca G, de Gaetano G (eds). Hemostasis, Prostaglandins and Renal Disease. New York : Raven Press, 1980 : 273 281
33. Noris M, Remuzzi G : Uremic bleeding: closing the circle after 30 years of controversies? Blood 94 : 2569 2574, 1999 (Pubitemid 29477284)
34. Zoja C, Noris M, Corna D, Vigano G, Perico N, de Gaetano G, Remuzzi G : l-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. Lab Invest 65 : 479 483, 1991
35. Gaarder A, Jonsen J, Laland S, Hellem A, Owren PA : Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192 : 531 532, 1961
36. Martin W, Villani GM, Jothianandan D, Furchgott RF : Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins. J Pharmacol Exp Ther 233 : 679 685, 1985 (Pubitemid 15019766)
37. Livio M, Gotti E, Marchesi D, Mecca G, Remuzzi G, de Gaetano G : Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 2 : 1013 1015, 1982 (Pubitemid 12035188)
38. Moia M, Mannucci PM, Vizzotto L, Casati S, Cattaneo M, Ponticelli C : Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Lancet 2 : 1227 1229, 1987 (Pubitemid 17163183)
39. Vigano G, Benigni A, Mendogni D, Mingardi G, Mecca G, Remuzzi G : Recombinant human erythropoietin to correct uremic bleeding. Am J Kidney Dis 18 : 44 49, 1991
40. Macdougall IC : Role of uremic toxins in exacerbating anemia in renal failure. Kidney Int Suppl 59 : S67 S72, 2001
41. Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini M, Figliuzzi M, Remuzzi G : Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 44 : 445 450, 1993 (Pubitemid 23228703)
42. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B : Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 37 : 116 125, 1990 (Pubitemid 20023775)
43. Shattil SJ, Bennett JS, McDonough M, Turnbull J : Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface. J Clin Invest 65 : 329 337, 1980 (Pubitemid 10159863)
44. Andrassy K, Ritz E : Uremia as a cause of bleeding. Am J Nephrol 5 : 313 319, 1985 (Pubitemid 15005689)
45. Bang NU, Tessler SS, Heidenreich RO, Marks CA, Mattler LE : Effects of moxalactam on blood coagulation and platelet function. Rev Infect Dis 4 (Suppl. S546 S554, 1982
46. Harter HR, Burch JW, Majerus PW, Stanford N, Delmez JA, Anderson CB, Weerts CA : Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301 : 577 579, 1979 (Pubitemid 10226452)
47. Lindsay RM, Ferguson D, Prentice CR, Burton JA, McNicol GP : Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet 2 : 1287 1290, 1972
48. Gaspari F, Vigano G, Orisio S, Bonati M, Livio M, Remuzzi G : Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J Clin Invest 79 : 1788 1797, 1987 (Pubitemid 17117287)
49. Boyle JM, Johnston B : Acute upper gastrointestinal hemorrhage in patients with chronic renal disease. Am J Med 75 : 409 412, 1983
50. Harker LA, Fuster V : Pharmacology of platelet inhibitors. J Am Coll Cardiol 8 : 21B 32B, 1986 (Pubitemid 17214363)
51. Castaldi PA, Rozenberg MC, Stewart JH : The bleeding disorder of uraemia. A qualitative platelet defect. Lancet 2 : 66 69, 1966
52. Reber G, Stoermann C, de Moerloose P, Ruedin P, Leski M : Hemostatic disturbances induced by two hollow-fiber hemodialysis membranes. Int J Artif Organs 15 : 269 276, 1992
53. Speiser W, Wojta J, Korninger C, Kirchheimer JC, Zazgornik J, Binder BR : Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis. Kidney Int 32 : 280 283, 1987 (Pubitemid 17130800)
54. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E : Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 98 : 2730 2735, 2001
55. Galbusera M, Noris M, Remuzzi G : Thrombotic thrombocytopenic purpura - then and now. Semin Thromb Hemost 32 : 81 89, 2006
56. Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ : Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 3 : 138 153, 2007 (Pubitemid 46327140)
57. Mattix H, Singh AK : Is the bleeding time predictive of bleeding prior to a percutaneous renal biopsy? Curr Opin Nephrol Hypertens 8 : 715 718, 1999 (Pubitemid 30029469)
58. Eknoyan G, Wacksman SJ, Glueck HI, Will JJ : Platelet function in renal failure. N Engl J Med 280 : 677 681, 1969
59. Larsson SO : On coagulation and fibrinolysis in renal failure. Scand J Haematol Suppl 15 : 1 59, 1971
60. Rabiner SF, Molinas F : The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med 49 : 346 351, 1970
61. Horowitz HI, Stein IM, Cohen BD, White JG : Further studies on the platelet inhibiting effect of guanidinisuccinic aid and its role in uremic bleeding. Am J Med 49 : 336 345, 1970
62. Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G : Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 22 : 347 353, 1978 (Pubitemid 9090298)
63. Nenci GG, Berrettini M, Agnelli G, Parise P, Buoncristiani U, Ballatori E : Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. I. Platelet aggregation by ADP and epinephrine. Nephron 23 : 287 292, 1979 (Pubitemid 9209400)
64. Sloand EM, Bern MM, Kaldany A : Effect on platelet function of hypoalbuminemia in peritoneal dialysis. Thromb Res 44 : 419 425, 1986 (Pubitemid 17200460)
65. Gordon LA, Perkins HA, Richards V, Rukes JM, Simon ER : Studies in regional heparinization. II. Artificial-kidney hemodialysis without systemic heparinization; preliminary report of a method using simultaneous infusion of heparin and protamine. N Engl J Med 255 : 1063 1066, 1956
66. Blaufox MD, Hampers CL, Merrill JP : Rebound anticoagulation occurring after regional heparinization for hemodialysis. Trans Am Soc Artif Intern Organs 12 : 207 209, 1966
67. Ivanovich P, Xu CG, Kwaan HC, Hathiwala S : Studies of coagulation and platelet functions in heparin-free hemodialysis. Nephron 33 : 116 120, 1983 (Pubitemid 13190898)
68. Casati S, Moia M, Graziani G, Cantaluppi A, Citterio A, Mannucci PM, Ponticelli C : Hemodialysis without anticoagulants: efficiency and hemostatic aspects. Clin Nephrol 21 : 102 105, 1984 (Pubitemid 14177564)
69. Fischer KG : Essentials of anticoagulation in hemodialysis. Hemodial Int 11 : 178 189, 2007
70. Saltissi D, Morgan C, Westhuyzen J, Healy H : Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation. Nephrol Dial Transplant 14 : 2698 2703, 1999 (Pubitemid 32208389)
71. Flanigan MJ, Von Brecht J, Freeman RM, Lim VS : Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation. Am J Kidney Dis 9 : 147 153, 1987 (Pubitemid 17042165)
72. Kelleher SP, Schulman G : Severe metabolic alkalosis complicating regional citrate hemodialysis. Am J Kidney Dis 9 : 235 236, 1987 (Pubitemid 17090583)
73. Fernandez F, Van Ryn J, Ofosu FA, Hirsh J, Buchanan MR : The haemorrhagic and antithrombotic effects of dermatan sulphate. Br J Haematol 64 : 309 317, 1986 (Pubitemid 16007298)
74. Boccardo P, Melacini D, Rota S, Mecca G, Boletta A, Casiraghi F, Gianese F : Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure. Nephrol Dial Transplant 12 : 2349 2354, 1997 (Pubitemid 27474618)
75. Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkoff-Rubin N : Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 304 : 934 939, 1981 (Pubitemid 11101081)
76. Swartz RD, Flamenbaum W, Dubrow A, Hall JC, Crow JW, Cato A : Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications. J Clin Pharmacol 28 : 818 825, 1988 (Pubitemid 19012988)
77. Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Suc JM, Boneu B : Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 59 : 139 148, 1985 (Pubitemid 15188829)
78. Gordge MP, Leaker B, Patel A, Oviasu E, Cameron JS, Neild GH : Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation. Thromb Res 57 : 171 182, 1990 (Pubitemid 20071067)
79. Lin FK, Suggs S, Lin CH, Browne JK, Smalling R, Egrie JC, Chen KK, Fox GM, Martin F, Stabinsky Z, Badrawi SM, Lai P-H, Goldwasser E : Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A 82 : 7580 7584, 1985 (Pubitemid 16204391)
80. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW : Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316 : 73 78, 1987 (Pubitemid 17052741)
81. van Geet C, Hauglustaine D, Verresen L, Vanrusselt M, Vermylen J : Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients. Thromb Haemost 61 : 117 121, 1989 (Pubitemid 19092680)
82. Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D : Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303 : 1318 1322, 1980 (Pubitemid 11194456)
83. Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS : Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308 : 8 12, 1983 (Pubitemid 13211265)
84. Vigano GL, Mannucci PM, Lattuada A, Harris A, Remuzzi G : Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia. Am J Hematol 31 : 32 35, 1989 (Pubitemid 19127428)
85. Shapiro MD, Kelleher SP : Intranasal deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. Am J Nephrol 4 : 260 261, 1984 (Pubitemid 14058859)
86. Canavese C, Salomone M, Pacitti A, Mangiarotti G, Calitri V : Reduced response of uraemic bleeding time to repeated doses of desmopressin. Lancet 1 : 867 868, 1985 (Pubitemid 15115132)
87. Mannucci PM : Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 90 : 2515 2521, 1997 (Pubitemid 27413458)
88. Liu YK, Kosfeld RE, Marcum SG : Treatment of uraemic bleeding with conjugated oestrogen. Lancet 2 : 887 890, 1984
89. Vigano G, Gaspari F, Locatelli M, Pusineri F, Bonati M, Remuzzi G : Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 34 : 853 858, 1988 (Pubitemid 19001705)
90. Sloand JA, Schiff MJ : Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia. Am J Kidney Dis 26 : 22 26, 1995
91. Mezzano D, Panes O, Munoz B, Pais E, Tagle R, Gonzalez F, Mezzano S, Barriga F, Pereira J : Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Thromb Haemost 82 : 1250 1254, 1999 (Pubitemid 29473787)
92. Mezzano D, Munoz B, Pais E, Downey P, Pereira J : Fast decrease of bleeding time by tranexamic acid in uremia. Thromb Haemost 83 : 785, 2000 (Pubitemid 30248530)
93. Vujkovac B, Lavre J, Sabovic M : Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. Am J Kidney Dis 31 : 536 538, 1998 (Pubitemid 28124111)
94. Vujkovac B, Sabovic M : Treatment of subdural and intracerebral haematomas in a haemodialysis patient with tranexamic acid. Nephrol Dial Transplant 15 : 107 109, 2000 (Pubitemid 30037941)
95. Sabovic M, Lavre J, Vujkovac B : Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transplant 18 : 1388 1391, 2003 (Pubitemid 36826962)
96. Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ : Authors' response to "Tranexamic acid and uremic bleeding: evidence-based treatment recommendations Nature Clin Pract Nephrol 3 : E3 E3, 2007
97. Roberts HR, Monroe DM, White GC : The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 104 : 3858 3864, 2004 (Pubitemid 39620130)
98. Hedner U, Ezban M : Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis. Annu Rev Med 59 : 29 41, 2008 (Pubitemid 351287922)
99. Revesz T, Arets B, Bierings M, van den Bos C, Duval E : Recombinant factor VIIa in severe uremic bleeding. Thromb Haemost 80 : 353, 1998
100. Moisescu E, Ardelean L, Simion I, Muresan A, Ciupan R : Recombinant factor VIIa treatment of bleeding associated with acute renal failure. Blood Coagul Fibrinolysis 11 : 575 577, 2000
101. Ng HJ, Koh LP, Lee LH : Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin. Ann Hematol 82 : 257 258, 2003 (Pubitemid 36701022)
102. Alioglu B, Avci Z, Baskin E, Ozcay F, Tuncay IC, Ozbek N : Successful use of recombinant factor VIIa (NovoSeven) in children with compartment syndrome: two case reports. J Pediatr Orthop 26 : 815 817, 2006 (Pubitemid 44655558)
103. Mannucci PM, Levi M : Prevention and treatment of major blood loss. N Engl J Med 356 : 2301 2311, 2007
104. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM : Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295 : 293 298, 2006 (Pubitemid 43112957)